Craniofacial hyperhidrosis successfully treated with botulinum toxin type A [8]

European Journal of Dermatology

Volumn 18, Issue 1, 2008, Pages 87-88

  Anders, Diana ^a   Moosbauer, Stephanie ^a   Naumann, Markus K ^b   Hamm, Henning ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b KLINIKUM AUGSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; CASE REPORT; CRANIOFACIAL HYPERHIDROSIS; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG TOLERABILITY; HUMAN; HYPERHIDROSIS; INJECTION SITE DISCOMFORT; LETTER; MALE;

ADULT; BOTULINUM TOXIN TYPE A; FOREHEAD; HUMANS; HYPERHIDROSIS; MALE; NEUROMUSCULAR AGENTS; SCALP;

EID: 38549092193     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)

1. Hornberger J, Grimes K, Naumann M et al. Recognition, diagnosis and treatment of primary focal hyperhidrosis. J Am Acad Dermatol 2004; 51: 274-86.
2. Strutton DR, Kowalski JW, Glaser DA, Stang PE. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol 2004; 51: 241-8.
3. Kinkelin I, Hund M, Naumann M, Hamm H. Effective treatment of frontal hyperhidrosis with botulinum toxin A. Br J Dermatol 2000; 143: 824-7.
4. Hamm H, Naumann M, Kowalski JW et al. Primary focal hyperhidrosis: disease characteristics and functional impairment. Dermatology 2006; 212: 343-53.
5. Naumann M, Lowe NJ, Kumar CR, Hamm H. Botulinum toxin type A is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study. Arch Dermatol 2003; 139: 731-6.
6. Lowe NJ, Yamauchi PS, Lask GP et al. Efficacy and safety of botulinum toxin type A in the treatment of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled study. Dermatol Surg 2002; 28: 822-7.
7. Boger A, Herath H, Rompel R, Ferbert A. Botulinum toxin for treatment of craniofacial hyperhidrosis. J Neurol 2000; 247: 857-61.